|
1
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Visone R and Croce CM: MiRNAs and cancer.
Am J Pathol. 174:1131–1138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Polyak K: Breast cancer: Origins and
evolution. J Clin Invest. 117:3155–3163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kravchenko J, Akushevich I, Seewaldt VL,
Abernethy AP and Lyerly HK: Breast cancer as heterogeneous disease:
Contributing factors and carcinogenesis mechanisms. Breast Cancer
Res Treat. 128:483–493. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fu SW, Chen L and Man YG: miRNA biomarkers
in breast cancer detection and nanagement. J Cancer. 2:116–122.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tanzer A, Amemiya CT, Kim CB and Stadler
PF: Evolution of microRNAs located within Hox gene clusters. J Exp
Zoolog B Mol Dev Evol. 304:75–85. 2005. View Article : Google Scholar
|
|
9
|
Chen C, Zhang Y, Zhang L, Weakley SM and
Yao Q: MicroRNA-196: Critical roles and clinical applications in
development and cancer. J Cell Mol Med. 15:14–23. 2011. View Article : Google Scholar
|
|
10
|
Hui AB, Shi W, Boutros PC, Miller N,
Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Waldron L, et
al: Robust global micro-RNA profiling with formalin-fixed
paraffin-embedded breast cancer tissues. Lab Invest. 89:597–606.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu XH, Lu KH, Wang KM, Sun M, Zhang EB,
Yang JS, Yin DD, Liu ZL, Zhou J, Liu ZJ, et al: MicroRNA-196a
promotes non-small cell lung cancer cell proliferation and invasion
through targeting HOXA5. BMC Cancer. 12:3482012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun M, Liu XH, Li JH, Yang JS, Zhang EB,
Yin DD, Liu ZL, Zhou J, Ding Y, Li SQ, et al: MiR-196a is
upregulated in gastric cancer and promotes cell proliferation by
downregulating p27kip1. Mol Cancer Ther. 11:842–852.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e179. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Helwak A, Kudla G, Dudnakova T and
Tollervey D: Mapping the human miRNA interactome by CLASH reveals
frequent noncanonical binding. Cell. 153:654–665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chou CP, Huang NC, Jhuang SJ, Pan HB, Peng
NJ, Cheng JT, Chen CF, Chen JJ and Chang TH: Ubiquitin-conjugating
enzyme UBE2C is highly expressed in breast microcalcification
lesions. PLoS One. 9:e939342014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Okamoto Y, Ozaki T, Miyazaki K, Aoyama M,
Miyazaki M and Nakagawara A: UbcH10 is the cancer-related E2
ubiquitin-conjugating enzyme. Cancer Res. 63:4167–4173.
2003.PubMed/NCBI
|
|
17
|
Luthra R, Singh RR, Luthra MG, Li YX,
Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, et al:
MicroRNA-196a targets annexin A1: A microRNA-mediated mechanism of
annexin A1 downregulation in cancers. Oncogene. 27:6667–6678. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Braig S, Mueller DW, Rothhammer T and
Bosserhoff AK: MicroRNA miR-196a is a central regulator of HOX-B7
and BMP4 expression in malignant melanoma. Cell Mol Life Sci.
67:3535–3548. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schimanski CC, Frerichs K, Rahman F,
Berger M, Lang H, Galle PR, Moehler M and Gockel I: High miR-196a
levels promote the oncogenic phenotype of colorectal cancer cells.
World J Gastroenterol. 15:2089–2096. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen
XM and Gao HJ: Initial study of microRNA expression profiles of
colonic cancer without lymph node metastasis. J Dig Dis. 11:50–54.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hussain M, Torres S, Schnettler E, Funk A,
Grundhoff A, Pijlman GP, Khromykh AA and Asgari S: West Nile virus
encodes a microRNA-like small RNA in the 3′ untranslated region
which up-regulates GATA4 mRNA and facilitates virus replication in
mosquito cells. Nucleic Acids Res. 40:2210–2223. 2012. View Article : Google Scholar :
|
|
23
|
Ma F, Liu X, Li D, Wang P, Li N, Lu L and
Cao X: MicroRNA-466l upregulates IL-10 expression in TLR-triggered
macrophages by antagonizing RNA-binding protein
tristetraprolin-mediated IL-10 mRNA degradation. J Immunol.
184:6053–6059. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van Ree JH, Jeganathan KB, Malureanu L and
van Deursen JM: Overexpression of the E2 ubiquitin-conjugating
enzyme UbcH10 causes chromosome missegregation and tumor formation.
J Cell Biol. 188:83–100. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pallante P, Berlingieri MT, Troncone G,
Kruhoffer M, Orntoft TF, Viglietto G, Caleo A, Migliaccio I,
Decaussin-Petrucci M, Santoro M, et al: UbcH10 overexpression may
represent a marker of anaplastic thyroid carcinomas. Br J Cancer.
93:464–471. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wagner KW, Sapinoso LM, El-Rifai W,
Frierson HF, Butz N, Mestan J, Hofmann F, Deveraux QL and Hampton
GM: Overexpression, genomic amplification and therapeutic potential
of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of
diverse anatomic origin. Oncogene. 23:6621–6629. 2004. View Article : Google Scholar : PubMed/NCBI
|
